Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Pfenex Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 8.54||$ 24.41|
|Low||$ 7.85||$ 6.50|
The current last sale of $8.50 is 30.77% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a clinical-stage biotechnology company engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and other high-value and difficult-to-manufacture proteins. Our lead product candidate is PF582, a biosimilar candidate to Lucentis (ranibizumab). Lucentis, marketed by Genentech, Inc., a wholly-owned member of the Roche Group and Novartis AG, for the treatment of patients with retinal diseases, achieved approximately $4.5 billion in global product sales in 2014. For PF582, we are conducting a Phase 1b/2a trial in patients with wet age-related macular degeneration, or wet AMD, with our collaboration partner, Hospira, Inc., or Hospira, a subsidiary of Pfizer Inc. (collectively with Hospira, "Pfizer"). Pfizer is responsible for manufacturing, clinical studies and commercialization of PF582 globally upon successful receipt of marketing approval. Our next most advanced product candidates are PF530 and PF708. ... More ...
Where does PFNX fit in the risk graph?
|Annual EPS Est:||$-1.26|
|Quarterly EPS Est:||-0.46|